Nyxoah S.A. (NYXH)
NASDAQ: NYXH · IEX Real-Time Price · USD
7.02
-0.08 (-1.13%)
At close: Jul 2, 2024, 3:53 PM
7.00
-0.02 (-0.28%)
After-hours: Jul 2, 2024, 4:34 PM EDT

Nyxoah Revenue

Nyxoah had revenue of $5.57M in the twelve months ending March 31, 2024, with 78.93% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.33M with 176.87% year-over-year growth. In the year 2023, Nyxoah had annual revenue of $4.83M with 47.25% growth.

Revenue (ttm)
$5.57M
Revenue Growth
+78.93%
P/S Ratio
43.27
Revenue / Employee
$38,177
Employees
146
Market Cap
241.21M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.83M1.55M47.25%
Dec 31, 20223.28M2.31M238.87%
Dec 31, 2021968.18K884.04K1,050.60%
Dec 31, 202084.15K--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Auna SA 1.06B
AngioDynamics 324.01M
Sutro Biopharma 154.07M
Aquestive Therapeutics 51.50M
Utah Medical Products 49.04M
Nanobiotix 40.23M
Molecular Partners AG 7.64M
Revenue Rankings